Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,106,772
  • Shares Outstanding, K 110,268
  • Annual Sales, $ 0 K
  • Annual Income, $ -85,900 K
  • 60-Month Beta 1.00
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.07
Trade VKTX with:

Options Overview Details

View History
  • Implied Volatility 71.90% ( -6.23%)
  • Historical Volatility 80.65%
  • IV Percentile 8%
  • IV Rank 30.58%
  • IV High 234.70% on 02/16/24
  • IV Low 0.20% on 02/27/24
  • Put/Call Vol Ratio 0.47
  • Today's Volume 17,745
  • Volume Avg (30-Day) 20,720
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 216,863
  • Open Int (30-Day) 192,645

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.24
  • Number of Estimates 10
  • High Estimate -0.21
  • Low Estimate -0.31
  • Prior Year -0.23
  • Growth Rate Est. (year over year) -4.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.70 +31.84%
on 09/06/24
69.99 -2.61%
on 08/21/24
+1.53 (+2.30%)
since 08/19/24
3-Month
46.11 +47.82%
on 06/26/24
70.96 -3.95%
on 07/26/24
+17.52 (+34.60%)
since 06/18/24
52-Week
8.28 +723.19%
on 10/26/23
99.41 -31.44%
on 02/28/24
+54.36 (+393.91%)
since 09/19/23

Most Recent Stories

More News
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments

Terns has a modest market cap of less than $800 million, and its possible upside could be massive.

LLY : 915.04 (+1.11%)
GS : 503.83 (+3.97%)
TERN : 10.04 (-1.67%)
VKTX : 68.16 (+5.76%)
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030

These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond.

MRK : 117.23 (-1.19%)
PFE : 29.66 (-0.30%)
MRNA : 68.02 (-2.63%)
VRTX : 477.90 (+0.79%)
VKTX : 68.16 (+5.76%)
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)

Telemedicine once seemed like it was going to revolutionize healthcare.

LLY : 915.04 (+1.11%)
PFE : 29.66 (-0.30%)
NVO : 134.88 (+2.14%)
TDOC : 9.18 (+0.99%)
AMZN : 189.87 (+1.85%)
NVDA : 117.87 (+3.97%)
SFIX : 4.18 (+0.97%)
VKTX : 68.16 (+5.76%)
ALT : 7.57 (+1.88%)
RHHBY : 39.4600 (-0.38%)
HIMS : 16.92 (+3.74%)
Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.

Terns Pharmaceuticals just proved that it's competitive in the weight loss field.

VKTX : 68.16 (+5.76%)
TERN : 10.04 (-1.67%)
These 2 Biotech Stocks Are Set to Soar

Innovative drugmakers developing treatments for conditions with high unmet needs can produce lucrative wins.

VKTX : 68.16 (+5.76%)
SRPT : 127.10 (+1.67%)
Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735

Recently revealed trial results for Roche's experimental weight-management drug suggest Viking Therapeutics is on the right track.

MS : 100.73 (+1.44%)
LLY : 915.04 (+1.11%)
VKTX : 68.16 (+5.76%)
RHHBY : 39.4600 (-0.38%)
Why Investors Plowed Into Viking Therapeutics Stock Today

The company is looking especially good after some bad news coming from a rival.

MS : 100.73 (+1.44%)
VKTX : 68.16 (+5.76%)
NVO : 134.88 (+2.14%)
LLY : 915.04 (+1.11%)
3 No-Brainer Biotech Stocks to Buy With $200 Right Now

An investment in these players today could score a big win down the road.

LLY : 915.04 (+1.11%)
GS : 503.83 (+3.97%)
NVO : 134.88 (+2.14%)
VKTX : 68.16 (+5.76%)
MRNA : 68.02 (-2.63%)
CRSP : 49.49 (-0.20%)
Why Viking Therapeutics Stock Rocked the Market Today

The biotech continued to get attention from both pundits and investors, thanks largely to its investigational obesity drug.

LLY : 915.04 (+1.11%)
JPM : 210.48 (+1.42%)
NVO : 134.88 (+2.14%)
VKTX : 68.16 (+5.76%)
Stocks Recover Early Losses and Close Higher as Chip Stocks Surge

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up by +1.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +2.17%. Stocks...

$SPX : 5,713.64 (+1.70%)
SPY : 570.98 (+1.71%)
$DOWI : 42,025.19 (+1.26%)
DIA : 421.41 (+1.25%)
$IUXX : 19,839.83 (+2.56%)
QQQ : 483.36 (+2.53%)
ZNZ24 : 114-310 (+0.20%)
ARM : 140.59 (+1.61%)
NVDA : 117.87 (+3.97%)
AVGO : 167.42 (+3.56%)
ASML : 828.16 (+5.12%)
KLAC : 772.43 (+5.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 72.20
2nd Resistance Point 70.20
1st Resistance Point 69.18
Last Price 68.16
1st Support Level 66.16
2nd Support Level 64.16
3rd Support Level 63.14

See More

52-Week High 99.41
Last Price 68.16
Fibonacci 61.8% 64.60
Fibonacci 50% 53.85
Fibonacci 38.2% 43.09
52-Week Low 8.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar